Publications by authors named "Daniel A Colon-Rios"

Claim this Profile
C
Correction: Harnessing ExDNA for precision Exatecan delivery in cancer: a novel antibody-drug conjugate approach.
Zaira Ianniello, Huimei Lu, Elias Quijano, Daniel A Colón-Ríos, Madison Rackear

Mol Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.
Daniel Andrés Colón-Ríos, Jonathan Dow, Adam Krysztofiak, Yanfeng Liu, Faye A Rogers

NAR Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.
Zaira Ianniello, Huimei Lu, Elias Quijano, Daniel A Colón-Ríos, Madison Rackear

Mol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition.
Madison Rackear, Elias Quijano, Zaira Ianniello, Daniel A Colón-Ríos, Adam Krysztofiak

Oncotarget· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct targeting of amplified gene loci for proapoptotic anticancer therapy.
Meetu Kaushik Tiwari, Daniel A Colon-Rios, Hemanta C Rao Tumu, Yanfeng Liu, Elias Quijano

Nat Biotechnol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulnerability of IDH1-Mutant Cancers to Histone Deacetylase Inhibition via Orthogonal Suppression of DNA Repair.
Jonathan Dow, Adam Krysztofiak, Yanfeng Liu, Daniel A Colon-Rios, Faye A Rogers

Mol Cancer Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis